Company Filing History:
Years Active: 2021
Title: The Innovations of Miyuki Kageyama
Introduction
Miyuki Kageyama is a notable inventor based in Koriyama, Japan. She has made significant contributions to the field of veterinary medicine, particularly in the treatment and diagnosis of canine atopic dermatitis. Her work has the potential to improve the quality of life for many dogs suffering from this condition.
Latest Patents
Kageyama holds a patent for an anti-canine TARC antibody used for the treatment and diagnosis of canine atopic dermatitis. This patent describes an anti-canine TARC monoclonal antibody that binds to canine TARC. The antibody comprises a heavy chain variable region with a specific amino acid sequence and a light chain variable region with another defined sequence. This innovation provides a method for treating or diagnosing canine atopic dermatitis effectively.
Career Highlights
Miyuki Kageyama is associated with Nippon Zenyaku Kogyo Co., Ltd., where she has been able to apply her research and innovations in a practical setting. Her work has garnered attention in the veterinary field, showcasing her dedication to improving animal health.
Collaborations
Kageyama has collaborated with notable colleagues such as Toshihiro Tsukui and Masahiro Kato. These partnerships have likely contributed to the advancement of her research and the successful development of her patented innovations.
Conclusion
Miyuki Kageyama's contributions to veterinary medicine through her innovative patent demonstrate her commitment to enhancing the treatment of canine atopic dermatitis. Her work is a testament to the impact that dedicated inventors can have on animal health and welfare.